SPDR S&P Pharmaceuticals ETF
XPH
XPH
71 hedge funds and large institutions have $259M invested in SPDR S&P Pharmaceuticals ETF in 2016 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 24 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
33% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 24
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
71
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$58.6M | |
| 2 | +$26M | |
| 3 | +$1.34M | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$850K |
| 5 |
WBG
Wharton Business Group
Malvern,
Pennsylvania
|
+$665K |
Top Sellers
| 1 | -$14.2M | |
| 2 | -$5.46M | |
| 3 | -$3.56M | |
| 4 |
EC
Estate Counselors
Thiensville,
Wisconsin
|
-$3.3M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$3.11M |